canine CKD, SCC, nonregenerative anemia case study, CKD의 새로운 지표 FGF-23에 관한 further study ppt 발표자료
- 최초 등록일
- 2021.06.13
- 최종 저작일
- 2021.05
- 26페이지/ MS 파워포인트
- 가격 1,500원
소개글
"canine CKD, SCC, nonregenerative anemia case study, CKD의 새로운 지표 FGF-23에 관한 further study ppt 발표자료"에 대한 내용입니다.
목차
1. Case study_Co-
1) Patient information – 2021. 05. 11
2) Objective Evaluation – 2021. 05. 13
3) Ddx
4) Assessment, Plan
2. Futher study
본문내용
B/A )
RBC_ 474 10000 (600 – 1010)
Hb_ 4.5 g/dl (8.1 – 14.2)
PCV_ 14.4 % (27.7 – 46.8)
MCV_ 30.5 fl (41.3 -52.6)
MCH_ 9.4 pg (12.6 – 16.0)
RDW_ 22.1 % (14.4 – 19.4)
#RETIC_43.2 10e/3 (15.0 – 81.0)
WBC_11060 /ul (6300 - 19600)
NEUT_ 85.4 % (29.5 – 74.5)
LYMPH_ 11.8 % (20.0 - 61.2)
EOS_ 0.5 % (3.4 – 11.4)
#NEUT_ 9.44 10e3/ ( 3.0 – 13.4)
#LYMPH_ 1.31 10e3/ (2.0 – 7.2)
#EOS_ 0.06 10e/3 (0.3 -1.7)
참고 자료
Physiological Actions of Fibroblast Growth Factor-23, Front. Endocrinol., 28 May 2018 | https://doi.org/10.3389/fendo.2018.00267
Serum fibroblast growth factor 23 (FGF-23): associations with hyperphosphatemia and clinical staging of feline chronic kidney disease , February 5, 2021, https://journals.sagepub.com/doi/full/10.1177/1040638720985563
Interaction between serum FGF-23 and PTH in renal phosphate excretion, a case-control study in hypoparathyroid patients https://bmcnephrol.biomedcentral.com/articles/10.1186/s12882-020-01826-5
FGF23 and the parathyroid glands https://pubmed.ncbi.nlm.nih.gov/20526631/